e.p.t.q. continues R&D to achieve the safety of dermal filler.

Do we need to worry about pain or side effects when we desire to be more beautiful and confident?
With e.p.t.q., you don’t need to worry about!

Low MoD

Low MoD is one of essential requirement of filler safety.
We strictly manage the safety of e.p.t.q. by checking the total amount of BDDE combined with HA molecules
(MoD ~1%).

100% crosslinked

e.p.t.q. manufacturing technology is creating a 100% crosslinked hydrogel allowing optimum rheological property with a minimum usage of BDDE.

Rheological property

Optimized rheological properties of e.p.t.q. give the best results of the procedure.

High cohesiveness

Cohesiveness is created by the internal adhesion forces of all its units to each other.
This internal adhesion forces depends on the concentration of HA and the crosslinking technique.
It reflects the ability to lift the tissues(volumizing effect).

As a result of ‘tack test’, e.p.t.q. has excellent cohesiveness, resulting in high lifting capacity and ability to hold the original shape.

Proven clinical data

e.p.t.q. manufacturing technology is creating a 100% crosslinked hydrogel allowing optimum rheological property with a minimum usage of BDDE.

Efficacy Assessment

From the WSRS(Wrinkle Severity Rating Scale) results (reduced compared to the baseline scores) evaluated by independent expert panels and blinded investigators, we were able to see the wrinkle improvement of the group.

Figure 1. WSRS mean value change at 8, 16 and 24 weeks compared to baseline assessed by blinded investigators.

Participant Self Satisfaction Assessment

Although there was no statistically significant difference in evaluating the satisfaction of the treatment with the tester and the subject’s GAIS(Global Aesthetic Improvement Scale), in general, the satisfaction level of the test group was similar or slightly higher than that of the control group.

Figure 2. GAIS mean values at 8, 16 and 24 weeks evaluated by subjects

Ref. Clinical Study Result, Department of Dermatology, Chung-Ang University Hospital, Korea 2017